Immediate Impact
2 by Nobel laureates 2 from Science/Nature 50 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Glioblastoma Therapy: Past, Present and Future
2024 Standout
Works of Dmitry Lyalin being referenced
Initial Testing (Stage 1) of MK‐8242—A Novel MDM2 Inhibitor—by the Pediatric Preclinical Testing Program
2016
Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing Program
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Dmitry Lyalin | 238 | 107 | 31 | 50 | 13 | 319 | |
| F. Cuttitta | 179 | 147 | 32 | 59 | 15 | 336 | |
| B. Heimann | 251 | 109 | 13 | 32 | 8 | 357 | |
| Emir Senturk | 209 | 141 | 23 | 18 | 14 | 368 | |
| Cristina Mariani | 186 | 120 | 27 | 27 | 16 | 315 | |
| Jeroen Overman | 246 | 62 | 12 | 84 | 13 | 334 | |
| Hana Andrlová | 177 | 101 | 15 | 64 | 12 | 298 | |
| Veronica Patton | 130 | 128 | 14 | 20 | 12 | 312 | |
| Takashi Ono | 208 | 111 | 22 | 33 | 14 | 371 | |
| Julia Meier | 222 | 69 | 13 | 47 | 17 | 339 | |
| Thomas S.K. Gilbert | 257 | 101 | 15 | 27 | 16 | 355 |
All Works
Login with ORCID to disown or claim papers
Loading papers...